Publication | Open Access

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Node-positive Breast CancerNeuro-oncologyBreast OncologyCns SubstudyMedicinePathologyBreast CancerCentral Nervous SystemCancer TreatmentOncologyRadiation OncologyHealth Sciences